MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Managing Patients After PCI
Combined dual-antiplatelet and anticoagulant therapy after PCI in patients with an indication for warfarin.
By Aslan T. Turer, MD, and J. Kevin Harrison, MD
Study Evaluates Balloon Postdilation in CoreValve TAVR Trials
February 3, 2017—A study of the impact of balloon postdilation (BPD) on outcomes in the United States clinical trials for the CoreValve transcatheter aortic valve replacement (TAVR) system (Medtronic) were published by J. Kevin Harrison, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2017;10:168–175).
Antithrombotic and Antiplatelet Therapies
By Ted E. Feldman, MD, FSCAI, Chief Medical Editor